The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
作者信息
White A, Cooper C, Stokes D
机构信息
Beecham Pharmaceuticals, Research Division, Betchworth, Surrey, England.
出版信息
Chemioterapia. 1987 Jun;6(2 Suppl):202-4.
PMID:3509934
Abstract
摘要
相似文献
1
The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
Chemioterapia. 1987 Jun;6(2 Suppl):202-4.
2
3
Ticarcillin plus clavulanic acid: pharmacokinetic study in renal failure.替卡西林加克拉维酸：肾衰竭患者的药代动力学研究
Chemioterapia. 1987 Jun;6(2 Suppl):265-7.
4
5
[New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
Jpn J Antibiot. 1991 Apr;44(4):365-87.
6
7
Beta-lactamase inhibition: therapeutic advances. Proceedings of a symposium. Fort Lauderdale, Florida, March 22-23, 1985.
Am J Med. 1985 Nov 29;79(5B):1-196.
8
[Therapy of infective respiratory diseases with a shielded beta-lactam antibiotic (amoxicillin and clavulanic acid)].用一种屏蔽型β-内酰胺抗生素（阿莫西林和克拉维酸）治疗感染性呼吸道疾病
Arch Monaldi Mal Torace. 1987 Nov-Dec;42(6):519-33.
9
[Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].[化疗药物的进展——β-内酰胺类抗生素与β-内酰胺酶抑制剂]
Nihon Rinsho. 1986 Apr;44(4):824-30.
10
[Clavulanic acid-shielded amoxicillin in the treatment of acute and chronic infective diseases of the pulmonary system].克拉维酸保护的阿莫西林治疗肺部系统急慢性感染性疾病
Arch Monaldi Mal Torace. 1987 Nov-Dec;42(6):535-49.
Zotero 插件